
    
      The study is designed to evaluate the impact of telemonitoring on the management of Diabetes
      Mellitus compared with outpatient usual care. From a clinical point of view, the measurements
      of HbA1c will be taken to assess glycaemic control and the trial will allow to investigate
      how telemonitoring contributes to improve Diabetes mellitus patients health-related quality
      of life and reduct the access to hospital facilities (re-hospitalizations, bed-days,
      specialistic and ER visits) and the anxiety about health conditions. A cost-effectiveness and
      cost-utility analysis will be carried out in order to determine if and how telemonitoring
      helps to limit the healthcare expenditure. The evaluation will deal also with organizational
      changes and task shift due to telemonitoring introduction and patients and professionals
      perception towards the service.
    
  